Physician profile
Andrew M Servinsky
NPI 1962495705
$3,334.28
in general payments reported to CMS, 2019-2025
14 companies · $509 in 2025
The $509 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $267 · 2020: $176 · 2021: $812 · 2022: $499 · 2023: $534 · 2024: $537 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,484 · Entertainment: $95.91.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,484.36 |
| Entertainment | $95.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,056.37 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $877.68 | 2019-2025 | Total30, Precision7, Precision 1 |
| Bausch & Lomb Americas INC. | $400.65 | 2022-2025 | Infuse, Miebo, Alden Scleral Zenlens |
| Tarsus Pharmaceuticals, INC. | $186.19 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $156.99 | 2019-2021 | |
| Dompe US, INC. | $151.70 | 2025 | Oxervate |
| Coopervision INC. | $110.31 | 2022-2024 | Myday Contact Lens, Onefit Contact Lens, Paragon Crt |
| Optos, INC. | $95.91 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sun Pharmaceutical Industries INC. | $88.92 | 2022-2025 | |
| Abbvie INC. | $87.29 | 2022-2023 | Alphagan P, Vuity, Lumigan |
| Lkc Technologies, INC. | $45.45 | 2024 | |
| Kala Pharmaceuticals, INC. | $39.45 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $19.99 | 2022 | |
| Allergan, INC. | $17.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Servinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.